Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Theravance Biopharma, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750…
The Emirate of Abu Dhabi 2016 Global Medium-Term Note Program and $5 Billion Notes Offering
Davis Polk advised the Dealers in connection with the preparation of a new global medium-term note program (the “Program”)…
Knowles Corporation $150 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles…
Knowles Corporation $150 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles…
Knowles Corporation $150 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles…
Knowles Corporation $150 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles…
Knowles Corporation $150 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Knowles…
Theravance Biopharma, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750…
The Emirate of Abu Dhabi 2016 Global Medium-Term Note Program and $5 Billion Notes Offering
Davis Polk advised the Dealers in connection with the preparation of a new global medium-term note program (the “Program”)…
Theravance Biopharma, Inc. Follow-On Offering
Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750…